Quinolone-isoniazid hybrids: synthesis and preliminary cytotoxicity and anti-tuberculosis evaluation.
Clicks: 282
ID: 104492
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
7.8
/100
26 views
26 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Herein, we propose novel quinolones incorporating an INH moiety as potential drug templates against TB. The quinolone-based compounds bearing an INH moiety attached a hydrazide-hydrazone bond were synthesised and evaluated against H37Rv (MTB). The compounds were also evaluated for cytotoxicity against HeLa cell lines. These compounds showed significant activity (MIC) against MTB in the range of 0.2-8 μM without any cytotoxic effects. Compounds (MIC; 0.9 μM), (MIC; 0.2 μM), (MIC; 0.8 μM) and compound (MIC; 0.8 μM), the most active compounds in this series, demonstrate activities on par with INH and superior to those reported for the fluoroquinolones. The SAR analysis suggests that the nature of substituents at positions -1 and -3 of the quinolone nucleus influences anti-MTB activity. Aqueous solubility evaluation and metabolic stability of compound highlights favourable drug-like properties for this compound class.
| Reference Key |
beteck2019quinoloneisoniazidmedchemcomm
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Beteck, Richard M;Seldon, Ronnett;Jordaan, Audrey;Warner, Digby F;Hoppe, Heinrich C;Laming, Dustin;Legoabe, Lesetja J;Khanye, Setshaba D; |
| Journal | medchemcomm |
| Year | 2019 |
| DOI |
10.1039/c8md00480c
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.